195 related articles for article (PubMed ID: 19773553)
1. Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme.
Zou K; Maeda T; Watanabe A; Liu J; Liu S; Oba R; Satoh Y; Komano H; Michikawa M
J Biol Chem; 2009 Nov; 284(46):31914-20. PubMed ID: 19773553
[TBL] [Abstract][Full Text] [Related]
2. Conversion of Aβ43 to Aβ40 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme.
Liu S; Liu J; Miura Y; Tanabe C; Maeda T; Terayama Y; Turner AJ; Zou K; Komano H
J Neurosci Res; 2014 Sep; 92(9):1178-86. PubMed ID: 24823497
[TBL] [Abstract][Full Text] [Related]
3. A clinical dose of angiotensin-converting enzyme (ACE) inhibitor and heterozygous ACE deletion exacerbate Alzheimer's disease pathology in mice.
Liu S; Ando F; Fujita Y; Liu J; Maeda T; Shen X; Kikuchi K; Matsumoto A; Yokomori M; Tanabe-Fujimura C; Shimokata H; Michikawa M; Komano H; Zou K
J Biol Chem; 2019 Jun; 294(25):9760-9770. PubMed ID: 31072831
[TBL] [Abstract][Full Text] [Related]
4. Aβ43 is the earliest-depositing Aβ species in APP transgenic mouse brain and is converted to Aβ41 by two active domains of ACE.
Zou K; Liu J; Watanabe A; Hiraga S; Liu S; Tanabe C; Maeda T; Terayama Y; Takahashi S; Michikawa M; Komano H
Am J Pathol; 2013 Jun; 182(6):2322-31. PubMed ID: 23562443
[TBL] [Abstract][Full Text] [Related]
5. Presenilin 1 deficiency impairs Aβ42-to-Aβ40- and angiotensin-converting activities of ACE.
Gao Y; Sun Y; Islam S; Nakamura T; Tomita T; Zou K; Michikawa M
Front Aging Neurosci; 2023; 15():1098034. PubMed ID: 36875692
[TBL] [Abstract][Full Text] [Related]
6. Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor.
Hemming ML; Selkoe DJ
J Biol Chem; 2005 Nov; 280(45):37644-50. PubMed ID: 16154999
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition.
Zou K; Yamaguchi H; Akatsu H; Sakamoto T; Ko M; Mizoguchi K; Gong JS; Yu W; Yamamoto T; Kosaka K; Yanagisawa K; Michikawa M
J Neurosci; 2007 Aug; 27(32):8628-35. PubMed ID: 17687040
[TBL] [Abstract][Full Text] [Related]
8. Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzyme.
Larmuth KM; Masuyer G; Douglas RG; Schwager SL; Acharya KR; Sturrock ED
FEBS J; 2016 Mar; 283(6):1060-76. PubMed ID: 26748546
[TBL] [Abstract][Full Text] [Related]
9. Catabolic attacks of membrane-bound angiotensin-converting enzyme on the N-terminal part of species-specific amyloid-beta peptides.
Sun X; Becker M; Pankow K; Krause E; Ringling M; Beyermann M; Maul B; Walther T; Siems WE
Eur J Pharmacol; 2008 Jun; 588(1):18-25. PubMed ID: 18495113
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity.
Hu J; Igarashi A; Kamata M; Nakagawa H
J Biol Chem; 2001 Dec; 276(51):47863-8. PubMed ID: 11604391
[TBL] [Abstract][Full Text] [Related]
11. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active.
Wei L; Alhenc-Gelas F; Corvol P; Clauser E
J Biol Chem; 1991 May; 266(14):9002-8. PubMed ID: 1851160
[TBL] [Abstract][Full Text] [Related]
12. The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors.
Wei L; Clauser E; Alhenc-Gelas F; Corvol P
J Biol Chem; 1992 Jul; 267(19):13398-405. PubMed ID: 1320019
[TBL] [Abstract][Full Text] [Related]
13. Neurotoxic Effects of Aβ6-42 Peptides Mimicking Putative Products Formed by the Angiotensin Converting Enzyme.
Medvedev AE; Radko SP; Yurinskaya MM; Vinokurov MG; Buneeva OA; Kopylov AT; Kozin SA; Mitkevich VA; Makarov AA
J Alzheimers Dis; 2018; 66(1):263-270. PubMed ID: 30282362
[TBL] [Abstract][Full Text] [Related]
14. Drosophila melanogaster angiotensin I-converting enzyme expressed in Pichia pastoris resembles the C domain of the mammalian homologue and does not require glycosylation for secretion and enzymic activity.
Williams TA; Michaud A; Houard X; Chauvet MT; Soubrier F; Corvol P
Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):125-31. PubMed ID: 8761461
[TBL] [Abstract][Full Text] [Related]
15. The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide.
Oba R; Igarashi A; Kamata M; Nagata K; Takano S; Nakagawa H
Eur J Neurosci; 2005 Feb; 21(3):733-40. PubMed ID: 15733091
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.
Rice GI; Thomas DA; Grant PJ; Turner AJ; Hooper NM
Biochem J; 2004 Oct; 383(Pt 1):45-51. PubMed ID: 15283675
[TBL] [Abstract][Full Text] [Related]
17. The N-domain of angiotensin-converting enzyme specifically hydrolyzes the Arg-5-His-6 bond of Alzheimer's Abeta-(1-16) peptide and its isoAsp-7 analogue with different efficiency as evidenced by quantitative matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Toropygin IY; Kugaevskaya EV; Mirgorodskaya OA; Elisseeva YE; Kozmin YP; Popov IA; Nikolaev EN; Makarov AA; Kozin SA
Rapid Commun Mass Spectrom; 2008; 22(2):231-9. PubMed ID: 18085519
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology.
Kehoe PG; Wong S; Al Mulhim N; Palmer LE; Miners JS
Alzheimers Res Ther; 2016 Nov; 8(1):50. PubMed ID: 27884212
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin I-converting enzyme transition state stabilization by HIS1089: evidence for a catalytic mechanism distinct from other gluzincin metalloproteinases.
Fernandez M; Liu X; Wouters MA; Heyberger S; Husain A
J Biol Chem; 2001 Feb; 276(7):4998-5004. PubMed ID: 11067854
[TBL] [Abstract][Full Text] [Related]
20. Iron treatment inhibits Aβ42 deposition in vivo and reduces Aβ42/Aβ40 ratio.
Shen X; Liu J; Fujita Y; Liu S; Maeda T; Kikuchi K; Obara T; Takebe A; Sayama R; Takahashi T; Matsue A; Sera K; Michikawa M; Komano H; Zou K
Biochem Biophys Res Commun; 2019 May; 512(4):653-658. PubMed ID: 30791980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
